ClinicalTrials.Veeva

Menu

Role of Transrectal-ultrasound in Evaluation of Azoospermia

A

Assiut University

Status

Unknown

Conditions

Infertility Due to Azoospermia

Treatments

Diagnostic Test: transrectal ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT05026190
infertility Azoospermia TRUS

Details and patient eligibility

About

Azoospermia is a word meaning to ejaculates with no spermatozoa without a definite underlying cause .1% of men has azoospermia, representing nearly 10 to 15% of all infertile men. The azoospermia is a major concern in our community. There is no actual epidemiological studies to estimate the actual numbers in Egypt. Azoospermia has several classifications, pre-testicular, testicular & post-testicular cause .The semen analysis is the main investigation done for these patient .The treatment methods range from hormonal therapy to surgery or ICSI . The imaging modalities has developed greatly in the last 3 decades. That it became in several setting as a bedside test or investigation. The main modalities used in azoospermia are scrotal ultrasound, TRUS and MRI. The first TRUS was introduced 1957.

Enrollment

50 estimated patients

Sex

Male

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • • Adult patients with azoospermia as identified by semen analysis.

    • Age from 18 years to more

Exclusion criteria

  • • History of operative intervention in the lower urinary tract.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

azoospermic patients
Other group
Treatment:
Diagnostic Test: transrectal ultrasound

Trial contacts and locations

0

Loading...

Central trial contact

mohamed m elsharkawy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems